Nektar Therapeutics Cash Flow-to-Debt Ratio
Nektar Therapeutics cash flow-to-debt ratio. Nektar Therapeutics (NKTR) has a Cash Flow-to-Debt Ratio of -0.39x as of June 2026, meaning its operating cash flow of $-75.77 Million could theoretically repay 0% of its total liabilities ($192.01 Million) in one year. Check cash flow quality index of Nektar Therapeutics to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Nektar Therapeutics (1994–2025)
Cash flow-to-debt ratio of Nektar Therapeutics from 1994 to 2025. Historical debt coverage capacity for Nektar Therapeutics across 32 annual periods. Check total reinvestment intensity of Nektar Therapeutics to assess the company's total reinvestment commitment from operating cash flow.
Nektar Therapeutics Cash Flow-to-Debt Ratio by Year (1994–2025)
Nektar Therapeutics cash flow-to-debt ratio by year from 1994 to 2025. Year-by-year debt coverage analysis for Nektar Therapeutics. For the full cash flow conversion analysis, see NKTR cash generation efficiency.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -1.09x | $-208.51 Million | $190.57 Million | ▼ -51.4% |
| 2024 | -0.72x | $-175.71 Million | $243.11 Million | ▼ -0.2% |
| 2023 | -0.72x | $-192.61 Million | $267.05 Million | ▲ +18.4% |
| 2022 | -0.88x | $-304.01 Million | $343.96 Million | ▲ +6.3% |
| 2021 | -0.94x | $-412.66 Million | $437.68 Million | ▼ -38.9% |
| 2020 | -0.68x | $-313.29 Million | $461.47 Million | ▼ -18.1% |
| 2019 | -0.57x | $-328.68 Million | $571.97 Million | ▼ -134.6% |
| 2018 | 1.66x | $718.21 Million | $432.60 Million | ▲ +969.3% |
| 2017 | -0.19x | $-80.41 Million | $421.04 Million | ▲ +21.5% |
| 2016 | -0.24x | $-117.02 Million | $480.75 Million | ▼ -65.1% |
| 2015 | -0.15x | $-73.08 Million | $495.63 Million | ▲ +57.9% |
| 2014 | -0.35x | $-142.01 Million | $405.29 Million | ▼ -376.9% |
| 2013 | -0.07x | $-38.53 Million | $524.43 Million | ▲ +74.5% |
| 2012 | -0.29x | $-129.76 Million | $450.77 Million | ▼ -3.4% |
| 2011 | -0.28x | $-113.74 Million | $408.74 Million | ▼ -114.4% |
| 2010 | -0.13x | $-55.87 Million | $430.56 Million | ▼ -254.5% |
| 2009 | 0.08x | $39.74 Million | $473.15 Million | ▲ +121.3% |
| 2008 | -0.39x | $-145.78 Million | $370.38 Million | ▼ -237.4% |
| 2007 | 0.29x | $146.30 Million | $510.66 Million | ▲ +267.2% |
| 2006 | -0.17x | $-92.72 Million | $541.12 Million | ▼ -16.8% |
| 2005 | -0.15x | $-78.00 Million | $531.74 Million | ▲ +47.9% |
| 2004 | -0.28x | $-78.14 Million | $277.58 Million | ▼ -67.2% |
| 2003 | -0.17x | $-76.20 Million | $452.60 Million | ▲ +10.2% |
| 2002 | -0.19x | $-74.97 Million | $399.87 Million | ▼ -46.6% |
| 2001 | -0.13x | $-50.77 Million | $396.93 Million | ▼ -25.9% |
| 2000 | -0.10x | $-35.74 Million | $351.66 Million | ▲ +7.1% |
| 1999 | -0.11x | $-15.33 Million | $140.18 Million | ▲ +89.4% |
| 1998 | -1.03x | $-19.22 Million | $18.61 Million | ▼ -570.2% |
| 1997 | 0.22x | $4.98 Million | $22.67 Million | ▲ +124.2% |
| 1996 | -0.91x | $-5.80 Million | $6.40 Million | ▲ +48.7% |
| 1995 | -1.77x | $-5.30 Million | $3.00 Million | ▲ +20.5% |
| 1994 | -2.22x | $-4.00 Million | $1.80 Million | — |